Blue Jet Healthcare Limited (BLUEJET) has broken below its support line and is down 5% intraday at ₹593.9.
Biocon Limited (BIOCON) announces the U.S. launch of Yesafili™, a biosimilar to Regeneron’s Eylea® 2 mg, expanding access to eye treatment.
Concord Biotech Limited (CONCORDBIO) stock moves up 5% intraday, nearing resistance at ₹1419. The stock is 0.
Syngene International Limited (SYNGENE) reports Q1 FY27 revenue at Rs. 736 Cr, with Operating EBITDA at Rs. 91 Cr.
Concord Biotech Limited (NSE: CONCORDBIO) stock extends gains, moving up 5% intraday to ₹1331.0, despite the 6M trendline status being CONSOLIDATING UP.
Anthem Biosciences Limited (NSE: ANTHEM) stock price falls 5% intraday to ₹746.1, breaking below support in a sectoral breakdown..
Anthem Biosciences Limited (NSE: ANTHEM) announces investor presentation on July 21, 2026, highlighting strategic updates and financial performance.
Anthem Biosciences Limited (NSE: ANTHEM) investor presentation highlights strong Q1FY27 performance with robust margins and promising future outlook.
Biocon Limited (NSE: BIOCON) stock moves up 5% intraday to ₹435.0, testing resistance in the healthcare & biotechnology sector.
Blue Jet Healthcare Limited (BLUEJET) stock clears its 6-month resistance trendline, recording a 6% intraday gain. Price now at ₹612.55.